Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pro Medicus Limited ( (AU:PME) ) just unveiled an announcement.
Pro Medicus Limited has secured a AUD $20 million, 5-year contract with University of Iowa Health Care to implement its Visage 7 Enterprise Imaging Platform across the institution. This agreement will replace the legacy PACS system with a cloud-based solution, enhancing diagnostic imaging and integrating with electronic health records. The rollout is set to begin immediately, with completion targeted for Q4 2025, marking a significant step in Pro Medicus’s expansion in the healthcare IT sector.
More about Pro Medicus Limited
Pro Medicus Limited is a leading health imaging company that provides advanced imaging solutions through its wholly-owned U.S. subsidiary, Visage Imaging, Inc. The company focuses on offering cloud-based enterprise imaging platforms, including Visage 7 Viewer, Workflow, and Open Archive, which are becoming standard in the North American healthcare IT market.
Average Trading Volume: 306,602
Technical Sentiment Signal: Buy
Current Market Cap: A$25.18B
For a thorough assessment of PME stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue